I-USP 175865-59-5 i-Valganciclovir hydrochloride ye-Antiviral
| Umkhiqizoigama | I-Valganciclovir hydrochloride |
| Omqondofana | L-Valine,2-[(2-aMino-1,6-dihydro-6-oxo-9H-purin-9-yl)Methoxy]-3-hydroxypropylester,hydrochloride(1:1);2-[(2-- i-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)methoxy]-3-hydroxypropyl(2S)-2-amino-3-methylbutanoatehydChemicalbookrochloridehydrate;L-Valine,2-[(2-amino- 1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropylester,monohydrochloridehydrate |
| Inombolo ye-CAS. | 175865-59-5 |
| Ukubukeka | I-crystalline powder emhlophe noma emhlophe |
| I-Molecular Formula | C14H22N6O5.HCl |
| Isisindo samangqamuzana | 390.83 |
| Ukusetshenziswa | Ibanga Lezemithi noma inhloso yocwaningo |
| Ukupakisha | Njengesicelo sakho |
| Isitoreji | Londoloza ezitsheni eziqinile, ezimelana nokukhanya endaweni epholile |
| I-Valganciclovir hydrochloride Cas:175865-59-5 | ||
| Izinto | Okujwayelekile | Imiphumela |
| Ukubukeka | I-crystalline powder emhlophe noma emhlophe | impushana emhlophe |
| Ukuhlonza | I-Infrared Absorption:Ihambisana naleyo yezinga lereferensiUkumuncwa kwe-Ultraviolet:Kuhambisana nalokho okujwayelekile kwereferensiIsixazululo emanzini (1 ku-20) sihlangabezana nezimfuneko zokuhlolwa kweChloride | Iyahambisana Iyahambisana
Iyahambisana |
| Isopropyl utshwala | ≤1.0% | 0.13% |
| Amanzi | ≤8.0% | 4.5% |
| Izinsimbi ezinzima | ≤20ppm | Iyahambisana |
| Pd | ≤10ppm | ＜10ppm |
| Izinsalela ekuthutheni | ≤0.1% | 0.02% |
| Ukungcola okuhlobene | I-Valganciclovir:I-Ganciclovir: ≤1.5%I-Guanine: ≤1.5% I-Methoxymethylguanine: ≤0.3% I-Isovalganciclovir: ≤0.5% I-Monoacetoxyganciclovir: ≤0.15% I-Bis-valine easter ye-ganciclovir: ≤0.1% I-Homologue ye-valganciclovir: ≤0.25% I-Imp H: ≤0.1% I-Imp I: ≤0.1% I-Ganciclovir monopropionate: ≤0.15% I-Valganciclovir dimer (stereoisomer A): ≤0.1% I-Valganciclovir dimer (stereoisomer B): ≤0.1% I-Valganciclovir dimer (stereoisomer C): ≤0.1% Okunye ukungcola okukhonjiwe okukodwa: ≤0.1% Isamba sobunye ukungcola okuhlonziwe: ≤0.1% I-Ganciclovir mono-N-methyl valinate (Ukuhlolwa 2):≤0.3% Ukungcola okukodwa okungaziwa (Ukuhlolwa 1 no-2): ≤0.1 % Isamba sokungcola okungaziwa (Ukuhlolwa 1 no-2): ≤0.25% Ukungcola okuphelele (Ukuhlolwa koku-1 nokuhlolwa kwesi-2): ≤3.0 | /0.02%0.01% 0.03% 0.02% ND 0.04% 0.01% 0.01% 0.004% ND ND ND ND Ubukhulu 0.04% 0.04%
0.02% Ubukhulu 0.02% 0.13% 0.78% |
| I-Diastereomer isilinganiso | 45:55 kuya ku-55:45 | 54:46 |
| Ukuhlanzeka kwe-Enantiomeric kwe-valganciclovir | ≥97.0% | 99.9% |
| Ukuhlolwa kwe-HPLC | 97.0%～102.0% | 98.8% |
| Isiphetho: ihambisana ne-USP40. | ||
Ulwazi Lwenkampani
√ Isipiliyoni esigcwele se-Management layer kubalandeli befektri nabanekhono; √ Ikhwalithi ihlale iwukucatshangelwa kwethu okuphezulu, uhlelo oluqinile lwe-QC; √ Ithimba leminyaka engu-11 elinesipiliyoni sokuthumela ngaphandle; √ Ilebhu ye-R&D ezimele; √ Izinkundla zokucobelelana ngolwazi ezimbili ze-GMP zesikhathi eside ezisayiniwe; √ Izinsiza ezicebile zamafekthri amaningi angasebenzi wephrojekthi eyenziwe ngokwezifiso; √ Ithimba elisebenzayo elisebenza kahle elinendlela engaguquki.
